SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sophie Janne who wrote (676)7/1/1999 7:23:00 AM
From: LORD ERNIE  Read Replies (1) of 857
 
Insider buy!!!!!

HEMISPHERX BIOPHARMA, INC. DIRECTOR FILES SEC FORM 4
WASHINGTON, DC, May. 28, 1999 (States via COMTEX) -- Midiand C. Piani of Neuilly, France, a Director of Hemispherx Biopharma, Inc. (SYMBOL: HEB), accumulated 2,400 shares for $6.69 each on April 19, 1999. Midiand C. Piani currently owns 2,400 shares. A Form 4 reporting the transaction was filed with the Securities and Exchange Commission on May 10, 1999.

--------------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News